Activation of Ras/PI3K/ERK Pathway Induces c-Myc Stabilization to Upregulate Argininosuccinate Synthetase, Leading to Arginine Deiminase Resistance in Melanoma Cells
- 14 May 2012
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 72 (10), 2622-2633
- https://doi.org/10.1158/0008-5472.can-11-3605
Abstract
Melanomas and other cancers that do not express argininosuccinate synthetase (AS), the rate-limiting enzyme for arginine biosynthesis, are sensitive to arginine depletion with pegylated arginine deiminase (ADI-PEG20). However, ADI resistance eventually develops in tumors because of AS upregulation. Although it has been shown that AS upregulation involves c-Myc, the underlying mechanisms remain unknown. Here we show that ADI-PEG20 activates Ras signaling and the effector extracellular signal–regulated kinase (ERK) and phosphoinositide 3-kinase (PI3K)/AKT/GSK-3β kinase cascades, resulting in phosphorylation and stabilization of c-Myc by attenuation of its ubiquitin-mediated protein degradation mechanism. Inhibition of the induced cell signaling pathways using PI3K/AKT inhibitors suppressed c-Myc induction and enhanced ADI-mediated cell killing. Notably, in an animal model of AS-negative melanoma, combination therapy using a PI3K inhibitor plus ADI-PEG20 yielded additive antitumor effects as compared with either agent alone. Taken together, our findings offer mechanistic insight into arginine deprivation metabolism and ADI resistance, and they illustrate how combining inhibitors of the Ras/ERK and PI3K/AKT signaling pathways may improve ADI-PEG20 anticancer responses. Cancer Res; 72(10); 2622–33. ©2012 AACR.Keywords
This publication has 49 references indexed in Scilit:
- A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancerNature Chemical Biology, 2011
- PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axisProceedings of the National Academy of Sciences of the United States of America, 2011
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivationNature, 2010
- Replacing Mn2+ with Co2+ in Human Arginase I Enhances Cytotoxicity toward l-Arginine Auxotrophic Cancer Cell LinesACS Chemical Biology, 2010
- Sodium Selenite Increases the Activity of the Tumor Suppressor Protein, PTEN, in DU-145 Prostate Cancer CellsNutrition and Cancer, 2009
- Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7The EMBO Journal, 2004
- A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cellsProceedings of the National Academy of Sciences, 2003
- Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-κB signalingOncogene, 2002
- Multiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityGenes & Development, 2000
- The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signalingBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2000